Skip to Content

135 (Nimodipine 30 mg)

Pill with imprint 135 is Yellow, Capsule-shape and has been identified as Nimodipine 30 mg. It is supplied by Caraco Pharmaceutical Laboratories.

Nimodipine is used in the treatment of subarachnoid hemorrhage and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nimodipine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 135

Nimodipine 30 mg 135

Nimodipine

Imprint:
135
Strength:
30 mg
Color:
Yellow
Size:
20.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcium channel blocking agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Caraco Pharmaceutical Laboratories
National Drug Code (NDC):
57664-0135
Inactive Ingredients:

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide